ALG.APV-527 First-in-human Study
Clinical trial NCT05934539 · UNKNOWN
Trial details
- NCT number
- NCT05934539
- Sponsor
- Aptevo Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-23
- Primary completion
- 2024-01-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.